Cutera (NASDAQ:CUTR) released its quarterly earnings data on Tuesday. The medical device company reported $0.11 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.03 by $0.08, Briefing.com reports. Cutera had a net margin of 11.16% and a negative return on equity of 0.50%. The firm had revenue of $40.60 million for the quarter, compared to the consensus estimate of $40.03 million. During the same quarter in the prior year, the company posted $0.42 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. Cutera updated its FY 2018 guidance to $0.40-0.50 EPS and its FY18 guidance to $0.40-0.50 EPS.
NASDAQ CUTR opened at $20.71 on Thursday. Cutera has a 1 year low of $19.11 and a 1 year high of $56.05. The firm has a market capitalization of $294.03 million, a PE ratio of 26.90 and a beta of 0.83.
In other news, insider James A. Reinstein bought 1,000 shares of Cutera stock in a transaction dated Wednesday, August 29th. The stock was purchased at an average price of $32.02 per share, for a total transaction of $32,020.00. Following the purchase, the insider now directly owns 139,907 shares in the company, valued at approximately $4,479,822.14. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.80% of the company’s stock.
Cutera Company Profile
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Recommended Story: Analyst Ratings
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.